Ergotamine relieves migraine by

A) Blocking vascular α adrenergic receptors B) Blocking vascular 5-HT₂ receptors C) Dilating cranial arterio-venous shunt channels D) Constricting cranial vessels and reducing perivascular neurogenic inflammation